Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.49 |
| ▸ | HTR6 | P50406 | 2/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.43 |
| ▸ | CA2 | P00918 | 2/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27876500 | 0.93 | HTR6 (0.50) | ALDH1A1HTR6KDM4ECA2SMN1; SMN2 | |
| SCHEMBL10180389 | 0.92 | HTR6 (0.58) | ALDH1A1HTR6CA2SMN1; SMN2POLB | |
| SCHEMBL10181468 | 0.86 | HTR6 (0.55) | ALDH1A1HTR6KDM4ESMN1; SMN2KMT2A | |
| SCHEMBL21064584 | 0.86 | ALDH1A1 (0.61) | ALDH1A1KDM4ESMN1; SMN2POLBKMT2A | |
| SCHEMBL103049 | 0.82 | GAA (0.61) | ALDH1A1KDM4ESMN1; SMN2POLBKMT2A | |
| SCHEMBL10181528 | 0.81 | NR1H2 (0.45) | ALDH1A1 | |
| SCHEMBL13703527 | 0.80 | CA2 (0.39) | ALDH1A1HTR6CA2SMN1; SMN2TSHR | |
| SCHEMBL23665873 | 0.79 | NPC1 (0.42) | ALDH1A1HTR6KDM4ECA2 | |
| SCHEMBL10180429 | 0.79 | PSIP1 (0.48) | ALDH1A1HTR6KDM4ECA2 | |
| SCHEMBL13241241 | 0.79 | ALDH1A1 (0.47) | ALDH1A1SMN1; SMN2LMNATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10312455-B2 | Delayed fluorescence material for organic electroluminescence device | LUMINESCENCE TECHNOLOGY CORP. (TW) | 2019-06-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10312455-B2 | Delayed fluorescence material for organic electroluminescence device | SOD1, GPX1, LEF1 | ALDH1A1 352/4885HTR6 2605/4885KDM4E 3381/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.